Koers Alternate Health Corp. Canadian Securities Exchange
Aandelen
AHG
CA02090B1022
Farmaceutische producten
Omzet 2017 | 13,25 mln. 9,72 mln. 8,97 mln. | Omzet 2018 | 577K 423K 391K | Marktkapitalisatie | 22,67 mln. 16,62 mln. 15,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -26 mln. -19,07 mln. -17,59 mln. | Nettowinst (verlies) 2018 | -24 mln. -17,6 mln. -16,24 mln. | EV/omzet 2017 | 6,25 x |
Nettoliquiditeiten 2017 | 893K 654K 604K | Nettoliquiditeiten 2018 | 773K 567K 523K | EV/omzet 2018 | 37,9 x |
K/w-verhouding 2017 |
-3,04
x | K/w-verhouding 2018 |
-0,76
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Mann
FOU | Founder | - | 11-12-18 |
Director of Finance/CFO | - | 25-01-18 | |
Chairman | - | 05-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James E. Tykoliz
BRD | Director/Board Member | - | 16-04-15 |
Chairman | - | 05-04-17 | |
Howard Mann
FOU | Founder | - | 11-12-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,29% | 6,02 mld. | |
-21,28% | 4,19 mld. | |
+4,52% | 3,25 mld. | |
-18,16% | 2,87 mld. | |
-7,70% | 2,37 mld. | |
+41,50% | 1,89 mld. | |
-4,05% | 1,58 mld. | |
-15,56% | 1,54 mld. | |
-14,62% | 1,5 mld. |